Brain Circulation

REVIEW ARTICLE
Year
: 2017  |  Volume : 3  |  Issue : 3  |  Page : 152--155

Drug treatments that optimize endogenous neurogenesis as a therapeutic option for stroke


Shyam N Dewan1, Yun Wang2, Seongjin Yu2 
1 Center of Excellence for Aging and Brain Repair, University of South Florida, Tampa, FL, USA
2 Center for Neuropsychiatric Research, National Health Research Institutes, Taiwan

Correspondence Address:
Seongjin Yu
Center for Neuropsychiatric Research, National Health Research Institutes
Taiwan

Cell death and neurogenesis have been examined after stroke in the subventricular zone of the adult mammalian brain. New research focuses on the use of drugs to improve the viability of neural progenitor cells in rats after stroke. The aim of the drugs is to lengthen the timeframe for stroke therapy by targeting the endogenous repair mechanism that follows injury. In this paper, we look at the broad state of stroke therapy to assess the effectiveness of endogenous neurogenesis-enhancing drugs on stroke. This paper is a review article. Referred literature in this paper has been listed in the reference section. The data sets supporting the conclusions of this article are available online by searching various databases, including PubMed. Some original points in this article come from the laboratory practice in our research center and the authors' experiences.


How to cite this article:
Dewan SN, Wang Y, Yu S. Drug treatments that optimize endogenous neurogenesis as a therapeutic option for stroke.Brain Circ 2017;3:152-155


How to cite this URL:
Dewan SN, Wang Y, Yu S. Drug treatments that optimize endogenous neurogenesis as a therapeutic option for stroke. Brain Circ [serial online] 2017 [cited 2022 Jun 25 ];3:152-155
Available from: http://www.braincirculation.org/article.asp?issn=2394-8108;year=2017;volume=3;issue=3;spage=152;epage=155;aulast=Dewan;type=0